Subscribe / Renew
|FAIRVIEW AVENUE NORTH BRIDGE REPLACEMENT, PW# 2016-029|
|FAIRVIEW AVE NORTH BRIDGE REPLACEMENT|
Walsh Construction Company II, LLC
February 18, 2010
Richland-based IsoRay hired William Cavanagh as vice president of research and development for IsoRay Medical. Cavanagh was chief scientific officer for Sangretech Biomedical for six years, overseeing design and use of a novel cancer therapy. IsoRay is a medical isotope company focusing on the treatment of prostate cancer and other malignant diseases.